Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia
NCT00294502Phase 4
Key facts
- Status
- Completed
- Start
- Sep 2003
- Countries
- 1
- Sponsor
- Henry Ford Health
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Conditions
- Bacteremia
01
Overview
Phase 4 trial of gentamicin, minocycline, trisodium citrate and ethylenediaminetetraacetic acid in Bacteremia, sponsored by Henry Ford Health. Primary endpoint: Incidence of symptomatic catheter-related bacteremia. Started Sep 2003; status: completed.
02
Design
1 armAntibiotic Lock Solution
Gentamycin/citrate or Minocycline/EDTA instilled into HD catheters after each treatment
03
Who it enrols
ESRD patients with tunnelled catheters, excluding those on IV antibiotics for infections or those with AV grafts/fistulas.
04
Endpoints
Primary
Incidence of symptomatic catheter-related bacteremia
Beyond the preview
Go deeper on NCT00294502.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294502.